FDA Charges Ranbaxy with Falsifying Data at India Plant
15:14 PM | March 9, 2009 | Deepti Ramesh
The U.S. FDA has charged Ranbaxy Laboratories (Gurgaon, India) with falsifying data and test results in approved and pending drug applications at the company’s Paonta Sahib, India facility. The agency...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.